Corporate Banner
Satellite Banner
Technology Networks Header
Friday, December 19, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bio-Rad Expands Portfolio of PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, May 21, 2014
Company expands its collection of validated assays for mutation detection and copy number variation.

Vitamin-mediated Cell Delivery of Oligonucleotides – an Attractive Approach for Therapeutic Applications
Wednesday, May 21, 2014
Link Technologies Ltd has announced the availability of a novel vitamin modifier, which has shown in initial tests to have the potential of improving cell delivery of oligonucleotides.

N-of-One to Provide Clinical Interpretation for Guardant360™ Tests
Monday, May 19, 2014
Breakthrough blood test enables next generation sequencing of solid tumor DNA.

Bespoke Instrumentation and Custom Manufacturing from Bibby Scientific
Wednesday, May 14, 2014
The company can produce solutions which directly meet with customer specs, ensuring that they get the results they require in the most accurate and reliable way possible.

Exiqon Launches XploreRNA™ app for Advanced Cross-Database Queries
Tuesday, May 13, 2014
XploreRNA™ will soon be available on Android and Windows platforms.

Exiqon Launches Exosome Isolation Kits for Analysis of Biofluids
Thursday, May 08, 2014
miRCURY™ Exosome Isolation kits ensure exosomes recovery in less than two hours.

Dako Launches Two Ready-to-Use Antibodies for Cancer Diagnosis
Wednesday, May 07, 2014
Company announces addition of Anti-CK 8/18 and Anti-TdT antibodies for routine diagnostic use.

VolitionRx Announces First Published Data in Anticancer Research Journal
Wednesday, April 30, 2014
The preliminary data, which demonstrated high detection rates for colorectal cancer, was the first to be publicly shared by the company last year

OGT Launch Cancer Sequencing Panel at ACGS
Wednesday, April 30, 2014
Accurate solid tumour profiling for clinical and translational research

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 667
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn